FOLR1

Across TCGA pan-cancer cohorts, FOLR1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated FOLR1 data layer compared with 25 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher FOLR1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated FOLR1 expression acts as an unfavorable survival marker.

SKCM, PRAD, and LIHC are the cancer types where FOLR1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	II,III,IV	0.294	0.718	.001	22	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
LIHC	DFS	Median	II,III,IV	0.044	0.427	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

FOLR1–SKCM (DFS)

Open the SKCM breakdown →